ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

HALESH PATEL MD FACP

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,678Medicare Part D Prescriptions Filled, Including Refills

Rank: 506 out of 2061

$547K Total Retail Price of All Prescriptions

Rank: 585 out of 2061

200 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

31% of this provider’s 200 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

36% of this provider’s 200 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 6,271 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

48 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
HYDROCODONE-ACETAMINOPHEN 498 288 S3 1 10
LEVOTHYROXINE SODIUM 363 262 2 3
LISINOPRIL 327 235 3 2
FUROSEMIDE 258 234 4 6
PRAVASTATIN SODIUM 250 182 5 14
METOPROLOL TARTRATE 245 161 6 7
RANITIDINE HCL 204 123 7 53
OMEPRAZOLE 193 142 8 5
GABAPENTIN 186 99 9 15
NEXIUM 182 78 10 26
SIMVASTATIN 177 128 11 1
OXYCODONE-ACETAMINOPHEN 176 102 S2 12 36
TIZANIDINE HCL 170 62 13 137
METFORMIN HCL 162 90 14 9
AMLODIPINE BESYLATE 150 128 15 4
ATORVASTATIN CALCIUM 148 109 16 8
WARFARIN SODIUM 127 95 17 11
CITALOPRAM HBR 126 82 18 20
CLOPIDOGREL 119 82 19 29
CARVEDILOL 113 87 20 22
OXYCODONE HCL-ACETAMINOPHEN 108 35 S2 21 114
LISINOPRIL-HYDROCHLOROTHIAZIDE 108 64 21 27
POTASSIUM CHLORIDE 101 84 23 16
PLAVIX 97 72 24 49
CRESTOR 96 45 25 31
MECLIZINE HCL 95 64 26 142
TRAZODONE HCL 94 29 27 39
FENOFIBRATE 85 58 28 65
NIASPAN 84 32 29 155
ALPRAZOLAM 84 61 29 85
AZITHROMYCIN 84 50 29 34
PROAIR HFA 83 60 32 40
CLONIDINE HCL 80 52 33 52
OXYCODONE HCL 80 43 S2 33 82
ROPINIROLE HCL 72 36 35 92
ZOLPIDEM TARTRATE 70 47 36 23
KLOR-CON M20 68 61 37 47
ISOSORBIDE MONONITRATE ER 64 37 38 42
METOPROLOL SUCCINATE 63 55 39 19
LANTUS SOLOSTAR 62 25 40 76
THEOPHYLLINE ANHYDROUS 61 37 41 201
ALLOPURINOL 60 37 42 28
TAMSULOSIN HCL 59 33 43 30
TRIAMTERENE-HCTZ 59 34 43 38
AMLODIPINE BESYLATE-BENAZEPRIL 59 47 43 79
ADVAIR DISKUS 56 40 46 57
SPIRONOLACTONE 55 35 47 62
SERTRALINE HCL 55 31 47 21
VITAMIN D2 53 52 49 146
CEFUROXIME 53 35 49 170
FLUTICASONE PROPIONATE 50 31 51 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 26, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.